A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
BACKGROUND: The increasing trend of women with unilateral breast cancer to electively undergo contralateral prophylactic mastectomy (CPM) in addition to treatment of the index breast has been the source of much debate. This trend has been primarily patient-driven, with conflicting, objective evidence supporting CPM. Critics have cautioned against the rising rates of CPM, questioning its indications and the possibility of increased risk over unilateral treatment. As such, any information thatdoi:10.1097/01.gox.0000547047.69041.27 fatcat:n2e2ardd55hnlpxsdxc5433ecq